ESC Premium Access

Fresh look at heart failure

Event: ESC CONGRESS 2017
Topic: Heart failure, other
Session type: Moderated Posters
Date: 29 August 2017
Time: 10:05 - 10:55

Congress Session

7 presentations in this session

Do beta-blockers improve one-year survival in heart failure patients with atrial fibrillation? Results from the ESC-HF Registry

Speaker: Doctor K. Ozieranski (Warsaw, PL)
Thumbnail

Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation in the PREFER in AF registry

Speaker: Associate Professor J. Siller-Matula (Vienna, AT)
Thumbnail

Association between serum potassium and clinical outcomes in UK patients with heart failure

Speaker: Ms L. Qin (Gaithersburg, US)
Thumbnail

Presence of micro- and macroalbuminuria and association with cardiac mechanics in type 2 diabetes

Speaker: Doctor P. Jorgensen (Hellerup, DK)
Thumbnail

Empagliflozin reduces heart failure irrespective of control of blood pressure, low density lipoprotein cholesterol and HbA1c

Speaker: Doctor D. Fitchett (Toronto, CA)
Thumbnail

Multi-ethnic comparisons of diabetes in heart failure with reduced ejection

Speaker: Doctor J. Yap (Singapore, SG)
Thumbnail

Short term effect of SGLT2 inhibitor, Dapagliflozin added on to standard therapy in decompensated heart failure patients with diabetes mellitus

Speaker: Doctor M. Nakagaito (Toyama, JP)
Thumbnail

7 speakers from this session

Doctor Krzysztof Ozieranski

Medical University of Warsaw, 1st Department of Cardiology, Warsaw (Poland)
0 follower

Associate Professor Jolanta Siller-Matula

Medical University of Vienna, Vienna (Austria)
1 presentation
0 follower

Ms Lei Qin

AstraZeneca, Gaithersburg (United States of America)
0 follower

Doctor Peter Godsk Jorgensen

Gentofte University Hospital, Department of Cardiology, Hellerup (Denmark)
0 follower

Doctor David Fitchett

St. Michael's Hospital, Toronto (Canada)
16 presentations
0 follower

Doctor Jonathan Yap

National Heart Centre Singapore (NHCS), Singapore (Singapore)
0 follower

Doctor Masaki Nakagaito

University of Toyama, Toyama (Japan)
0 follower

This platform is supported by

logo Novo Nordisk